Recent studies showed high levels of Tomm34 expressed in colorectal cancer [15], hepatocellular carcinoma [16], bladder cancer [17], breast cancer [18, 19] epithelial ovarian cancer [20] and colon cancer [21] compared to their normal tissue counterparts. Here, TOMM34 is linked to urinary bladder carcinoma.